Actively Recruiting
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Led by Leslie Thompson · Updated on 2026-04-13
21
Participants Needed
1
Research Sites
247 weeks
Total Duration
On this page
Sponsors
L
Leslie Thompson
Lead Sponsor
C
California Institute for Regenerative Medicine (CIRM)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
CONDITIONS
Official Title
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have decision-making capacity and be able to provide written informed consent.
- Are between 18 to 65 years of age
- Have genetically confirmed diagnosis of Huntington's Disease
- Able to undergo MRI scans, tolerate neurosurgical procedure, blood draws and lumbar puncture.
You will not qualify if you...
- Are pregnant
- Test positive for human immunodeficiency virus (HIV), hepatitis C or chronic hepatitis B at Screening
- Have an implanted deep brain stimulation device.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Irvine
Irvine, California, United States, 92697
Actively Recruiting
Research Team
U
UCI Alpha Clinic
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here